Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

15.35
Delayed Data
As of Dec 02
 +0.20 / +1.32%
Today’s Change
13.95
Today|||52-Week Range
30.09
-42.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization197.0K333.0K578.0K734.0K
 
 
 
 
 
 
Operating ExpensesGross Income---333.0K-578.0K-734.0K
 
 
 
 
General Expenses23.6M54.1M74.0M96.2M
 
 
 
 
 
Research And Development15.0M32.8M54.8M61.2M
 
 
 
 
 
Total Operating Expenses23.8M54.5M74.6M96.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.8M-54.5M-74.6M-96.9M
 
 
 
 
 
Interest Expense On Debt599.0K826.0K887.0K958.0K
 
 
 
 
 
Other Expenses0.000.00-919.0K292.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.4M-55.3M-76.4M-97.6M
 
 
 
 
 
Discontinued Operations1.1M0.000.000.00
 
 
Net Income-23.3M-55.3M-76.4M-97.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.2M16.2M26.6M33.1M
 
 
 
 
 
Shares To Calculate EPS Diluted12.2M16.2M26.6M33.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.00-$3.42-$2.87-$2.95
 
 
 
 
 
EPS Diluted-$2.00-$3.42-$2.87-$2.95